REIMBURSEMENT FOR RADIO/MICROWAVE-BASED BPH TREATMENTS KEY TO WIDESPREAD USE; INSURERS LIKELY TO TIE COVERAGE DECISIONS TO PUBLICATION OF DURABILITY DATA